Pretreatment With Neurokinin Substance P But Not With Cholecystokinin-8S Can Alleviate Functional Deficits of Partial Nigrostriatal 6-Hydroxydopamine Lesion
Authors:
- J.P HustonJHJ.P Huston
- B KörberBKB Körber
- C ThielCTC Thiel
- R.K.W SchwartingRSR.K.W Schwarting
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Neurokinin-3 receptors modulate dopamine cell function and alter the effects of 6-hydroxydopamineBrain Research, 1995
- Functions of brain-derived neurotrophic factor, insulin-like growth factor-I and basic fibroblast growth factor in the development and maintenance of dopaminergic neuronsProgress in Neurobiology, 1994
- Efficacy of Brain‐Derived Neurotrophic Factor and Neurotrophin‐3 on Neurochemical and Behavioral Deficits Associated with Partial Nigrostriatal Dopamine LesionsJournal of Neurochemistry, 1994
- Substance P decreases extracellular concentrations of acetylcholine in neostriatum and nucleus accumbens in vivo: Possible relevance for the central processing of reward and aversionBehavioural Brain Research, 1994
- Effects of substance P on extracellular dopamine in neostriatum and nucleus accumbensEuropean Journal of Pharmacology, 1992
- Cholecystokinin-dopamine intearctionsTrends in Pharmacological Sciences, 1991
- Substance P-dopamine relationship in the rat substantia nigra: a light and electron microscopy study of double immunocytochemically labeled materialsBrain Research, 1988
- CholecystokininProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1988
- Saturable transport of peptides across the blood-brain barrierLife Sciences, 1987
- Relationship of changes in spontaneous motor activity to spontaneous circling in rats with unilateral 6-hydroxydopamine lesions of the substantia nigraExperimental Neurology, 1986